ROBERT J FLANAGAN
CIK 1251512 · last filed 2025-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.51M
Companies
4
Total Filings
49
Lifetime Open-Market Net
-$12.64M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WPC | Director | 19,638 | $76.71 | $1.51M | $82.3K | 10 | 2025-07-02 |
| Sagent Pharmaceuticals, Inc. (SGNT) Delisted | Director | 13,970 | — | — | -$13.73M | 26 | 2016-02-25 |
| MARTEK BIOSCIENCES CORP (MATK) Delisted | Director | 0 | — | — | $0 | 7 | 2011-02-25 |
| Castle Brands Inc (ROX) Delisted | Director | 638,287 | — | — | $1.00M | 4 | 2008-09-25 |
Recent Filings · Page 4 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-05-13 | Sagent Pharmaceuticals, Inc. (SGNT) Delisted | Exer (M) | +1,276 | $5.4K | EDGAR |
| 2013-02-25 | Sagent Pharmaceuticals, Inc. (SGNT) Delisted | Mixed | +567 | $0 | EDGAR |
| 2012-05-14 | Sagent Pharmaceuticals, Inc. (SGNT) Delisted | Exer (M) | +1,275 | $5.4K | EDGAR |
| 2012-04-19 | Sagent Pharmaceuticals, Inc. (SGNT) Delisted | Mixed | +277 | $5.4K | EDGAR |
| 2012-02-24 | Sagent Pharmaceuticals, Inc. (SGNT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-11-23 | Sagent Pharmaceuticals, Inc. (SGNT) Delisted | Buy (P) | +1,000 | $20.2K | EDGAR |
| 2011-08-17 | Sagent Pharmaceuticals, Inc. (SGNT) Delisted | Buy (P) | +2,000 | $39.7K | EDGAR |
| 2011-03-01 | — | Mixed | — | -$79.8K | |
| 2011-02-25 | MARTEK BIOSCIENCES CORP (MATK) Delisted | U | −351,284 | -$11.07M | EDGAR |
| 2010-03-22 | MARTEK BIOSCIENCES CORP (MATK) Delisted | Mixed | +3,515 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.